The Advocacy Committee proactively identifies regulatory, reimbursement and practice challenges affecting the International Clinical Cytometry community’s ability to deliver patient care in all geographies.
The Advocacy Committee alerts ICCS and its associated clinical flow cytometry societies to these issues, and invites them in turn to alert The Advocacy Committee similarly.
When possible and appropriate, the Advocacy Committee and ICCS membership will engage with stakeholder groups and agencies in order to provide expert guidance in the area of clinical flow cytometry to thereby ensure patient access to this crucial diagnostic modality.
Interested in joining the Advocacy Committee? Use the link in the right menu to download the application and submit it to info@cytometry.org.
FDA Webinar – Final Rule: Medical Devices; Laboratory Developed Tests (May 14, 2024)
Upcoming FDA Webinars/CDRH Events including IVD Classification (July 2024) and MDRs, Quality System Complaint requirements, and Recalls (August 2024)